Ana Rovira

9PUBLICATIONS
48CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 22, 2025
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression.

Anna Rea, Sara Santana-Hernández, Javier Villanueva

|Feb 26, 2025
Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer.

Juan Madoz-Gúrpide, Juana Serrano-López, Marta Sanz-Álvarez

|Feb 03, 2025
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Alice Perucca, Andrea Gómez Llonín, Oriol Mañé Benach

|Apr 13, 2023
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer.

Paula Cabello, Sandra Torres-Ruiz, Anna Adam-Artigues

|Nov 11, 2022
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.

Birlipta Pattanayak, Ana Lameirinhas, Sandra Torres-Ruiz

|May 20, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer.

Anna Adam-Artigues, Enrique J Arenas, Alex Martínez-Sabadell

Pageof 2